You are currently viewing a new version of our website. To view the old version click .

Novel Targets and Mechanisms in Antimicrobial Drug Discovery

Special Issue Information

Dear Colleagues,

The spread of infections resistant to available anti-infective drugs is a serious menace to human, animal, and environmental safety. WHO predicts that, by 2050, microbial resistance will cause the death of 50 million people, thereby becoming the leading cause of death. In this context, the discovery of innovative bio-active molecules as well as the validation of new targets is impelling and could represent a valid solution to curb the continuing emergence and spreading of resistant infections.

In this perspective, the issue welcomes contributions from scientists working on antimicrobial resistance, with a special attention to novel targets, innovative strategies, and molecular entities targeting infectious diseases caused by bacteria, parasites, viruses, and fungi.

With this Special Issue, Antibiotics means to give a glimpse into state-of-the-art work in medicinal chemistry research in the field. Both reviews and research articles are welcomed.

Dr. Donatella Tondi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Drug design
  • small molecules
  • antimicrobial resistance mechanisms
  • new targets validation
  • computational chemistry
  • structural biology
  • natural products
  • drug repurposing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382